Diveradgel Co., Ltd
Our mission is to create groundbreaking cancer immunotherapies that offer hope for curing refractory cancers, and ultimately reduce the suffering of cancer patients. At the core of our development pipeline is a cancer vaccine utilizing Sonanos™, a hyaluronic acid nanogel with immune cell-targeting capabilities. Furthermore, we are advancing the development of a combination therapy with Sonanos™ cancer vaccine and genetically engineered T-cell therapy, offering potential for remission and prevention of recurrence in refractory cancers.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Diveradgel Co., Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Diveradgel Co., Ltd
2 distinct titles indexed · top 2 shown.
- 1coo
- 1diveradgel co, ltd
Sign up to unlock all 3 contacts at Diveradgel Co., Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Diveradgel Co., Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.